biomarkers for more stability in life
biomarkers for more stability in life
latest news
Unique miRNome and transcriptome profiles underlie microvascular heterogeneity in mouse kidney
We want to draw your attention to our latest publication which appeared in American Journal of Physiology-Renal Physiology. We could show that laser microdissection combined with (small) RNA sequencing [...]
TAmiRNA at RNA Leaders conference
TAmiRNA CEO/CSO Matthias Hackl will attend the RNA Leaders conference in Boston next week to speak about how cell-free RNA biomarkers can be incorporated in pre-clinical and clinical development to [...]
TAmiRNA presenting miND® NextGen sequencing opportunities at ISSX/DMDG 2023 Meeting
TAmiRNA will be a significant contributor to the inaugural joint European meeting of the ISSX and DMDG respectively focused on xenobiotics and drug metabolics. Dr. Matthias Hackl, CEO and [...]
Unique miRNome and transcriptome profiles underlie microvascular heterogeneity in mouse kidney
We want to draw your attention to our latest publication which appeared in American Journal of Physiology-Renal Physiology. We could show that laser microdissection combined with (small) RNA sequencing revealed renal microvascular [...]
TAmiRNA at RNA Leaders conference
TAmiRNA CEO/CSO Matthias Hackl will attend the RNA Leaders conference in Boston next week to speak about how cell-free RNA biomarkers can be incorporated in pre-clinical and clinical development to inform about drug [...]
TAmiRNA presenting miND® NextGen sequencing opportunities at ISSX/DMDG 2023 Meeting
TAmiRNA will be a significant contributor to the inaugural joint European meeting of the ISSX and DMDG respectively focused on xenobiotics and drug metabolics. Dr. Matthias Hackl, CEO and co-founder, will take [...]